Advertisement

Quality of life impairment in bipolar disorder

  • Erin E. Michalak
  • Greg Murray
  • Allan H. Young
  • Raymond W. Lam
Chapter

Abstract

This chapter will present an overview of what is currently known about quality of life (QoL) in bipolar disorder (BD). While there is growing consensus that the QoL concept provides an important counterpoint to the objective symptom measures that dominate psychiatry, the implications of this position are yet to be systematically addressed in the BD field. The literature reviewed in this chapter is not informed by any model or theory of QoL as it applies to BD. The data presented are largely empirical in the negative sense of this term, drawn from studies making different assumptions, addressing different questions in BD. In many cases, the measurement of QoL has been incidental to the major thrust of the research design. Indeed, even at the empirical level there is a lack of agreement about the best measure of QoL in this population, and no disorder-specific measure currently exists. In this context, the present chapter aims to capture the range of applications of the QoL concept in BD, and highlight any reliable findings. To structure the presentation, it is useful to categorize data into three general areas: studies that have looked at QoL impairment in BD compared with non-clinical and other diagnostic groups, studies that have looked at QoL differences across the states of BD and studies that have looked at QoL changes as an outcome of treatment. We will briefly set the scene for these three investigations by presenting the findings of four manuscripts that have reviewed research into QoL and BD. The final section of this chapter will make some recommendations about future QoL research in BD, highlighting the need for work at both the theoretical and measurement levels. At the theoretical level, the implications of the vulnerability model of health-related QoL (HRQOL) (e.g., Ritsner, Chapter of this collection) will be briefly reviewed. At the measurement level, we will present some data on the ongoing development of a patient-centred disorder-specific QoL measure for BD

Key words

Bipolar disorder Quality of life Functioning 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., and Keller, M. B. The Long-Term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder. Archives of General Psychiatry 2002; 59(6): 530–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Judd, L. L., Schettler, P. J., Akiskal, H. S., Maser, J., Coryell, W., Solomon, D., Endicott, J., and Keller, M. Long-Term Symptomatic Status of Bipolar I Vs. Bipolar II Disorders. Int.J.Neuropsychopharmacol. 2003; 6(2): 127–37.PubMedCrossRefGoogle Scholar
  3. 3.
    Murray, C. J. and Lopez, A. D. Global Mortality, Disability, and the Contribution of Risk Factors: Global Burden of Disease Study. Lancet 5-17-1997; 349(9063): 1436–42.CrossRefGoogle Scholar
  4. 4.
    US DHEW Medical Practice Project. A State of the Service Report for the Office of the Assistant Secretary for the US Dept of Health, Education and Welfare. Policy Research. 1979.Google Scholar
  5. 5.
    Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., Wittchen, H., and Yeh, E. K. Cross-National Epidemiology of Major Depression and Bipolar Disorder. JAMA 7-24-1996; 276(4): 293–9.CrossRefGoogle Scholar
  6. 6.
    Angst, J. The Emerging Epidemiology of Hypomania and Bipolar II Disorder. J.Affect.Disord. 1998;50(2–3):143–51.PubMedCrossRefGoogle Scholar
  7. 7.
    Wyatt, R. J. and Henter, I. An Economic Evaluation of Manic-Depressive Illness–1991. Soc.Psychiatry Psychiatr.Epidemiol. 1995; 30(5): 213–9.PubMedGoogle Scholar
  8. 8.
    Colom, F. and Vieta, E. A Perspective on the Use of Psychoeducation, Cognitive-Behavioral Therapy and Interpersonal Therapy for Bipolar Patients. Bipolar Disord. 2004; 6(6): 480–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Namjoshi, M. A. and Buesching, D. P. A Review of the Health-Related Quality of Life Literature in Bipolar Disorder. Qual.Life Res. 2001; 10(2): 105–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Dean, B. B., Gerner, D., and Gerner, R. H. A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Healthcare Costs and Utilization in Bipolar Disorder. Curr.Med.Res.Opin. 2004; 20(2): 139–54.PubMedCrossRefGoogle Scholar
  11. 11.
    Revicki, D. A., Matza, L. S., Flood, E., and Lloyd, A. Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials. Pharmacoeconomics. 2005; 23(6): 583–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Michalak, E. E., Yatham, L. N., and Lam, R. W. Quality of Life in Bipolar Disorder: a Review of the Literature. Health Qual.Life Outcomes. 2005;3:72.Google Scholar
  13. 13.
    Stewart, A. L., Hays, R. D., and Ware, J. E., Jr. The MOS Short-Form General Health Survey. Reliability and Validity in a Patient Population. Med.Care 1988; 26(7): 724–35.PubMedCrossRefGoogle Scholar
  14. 14.
    Arnold, L. M., Witzeman, K. A., Swank, M. L., McElroy, S. L., and Keck, P. E., Jr. Health-Related Quality of Life Using the SF-36 in Patients With Bipolar Disorder Compared With Patients With Chronic Back Pain and the General Population. J.Affect.Disord. 2000;57(1–3):235–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Yatham, L. N., Lecrubier, Y., Fieve, R. R., Davis, K. H., Harris, S. D., and Krishnan, A. A. Quality of Life in Patients With Bipolar I Depression: Data From 920 Patients. Bipolar Disord. 2004; 6(5): 379–85.PubMedCrossRefGoogle Scholar
  16. 16.
    Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. The WHOQOL Group. Psychological Medicine 1998; 28(3): 551–8.CrossRefGoogle Scholar
  17. 17.
    Berlim, M. T., Pargendler, J., Caldieraro, M. A., Almeida, E. A., Fleck, M. P., and Joiner, T. E. Quality of Life in Unipolar and Bipolar Depression: Are There Significant Differences? J.Nerv.Ment.Dis. 2004; 192(11): 792–5.PubMedCrossRefGoogle Scholar
  18. 18.
    ten Have, M., Vollebergh, W., Bijl, R., and Nolen, W. A. Bipolar Disorder in the General Population in The Netherlands (Prevalence, Consequences and Care Utilisation): Results From The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J.Affect.Disord. 2002;68(2–3):203–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Williams, J. B. W., Gibbon, M., and First, M. B. The Structured Clinical Interview for DSM-III-R (SCID), I: History, Rationale, and Description. Archives of General Psychiatry 1992;49:624–9.PubMedGoogle Scholar
  20. 20.
    Chand, P. K., Mattoo, S. K., and Sharan, P. Quality of Life and Its Correlates in Patients With Bipolar Disorder Stabilized on Lithium Prophylaxis. Psychiatry Clin.Neurosci. 2004; 58(3): 311–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Endicott, J., Nee, J., Harrison, W., and Blumenthal, R. Quality of Life Enjoyment and Satisfaction Questionnaire: a New Measure. Psychopharmacol.Bull. 1993; 29(2): 321–6.PubMedGoogle Scholar
  22. 22.
    Schechter, D, Endicott, J., and Nee, J. Quality of Life of ‘Normal’ Controls: Association With Lifetime History of Mental Illness. In press, Psychiatry Research.Google Scholar
  23. 23.
    Atkinson, M., Zibin, S., and Chuang, H. Characterizing Quality of Life Among Patients With Chronic Mental Illness: a Critical Examination of the Self-Report Methodology. Am.J.Psychiatry 1997; 154(1): 99–105.PubMedGoogle Scholar
  24. 24.
    Ferrans, C. E. and Powers, M. J. Psychometric Assessment of the Quality of Life Index. Res.Nurs.Health 1992; 15(1): 29–38.PubMedCrossRefGoogle Scholar
  25. 25.
    Dell’Osso, L., Pini, S., Cassano, G. B., Mastrocinque, C., Seckinger, R. A., Saettoni, M., Papasogli, A., Yale, S. A., and Amador, X. F. Insight into Illness in Patients With Mania, Mixed Mania, Bipolar Depression and Major Depression With Psychotic Features. Bipolar.Disord. 2002; 4(5): 315–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Ghaemi, S. N., Stoll, A. L., and Pope, H. G., Jr. Lack of Insight in Bipolar Disorder. The Acute Manic Episode. J.Nerv.Ment.Dis. 1995; 183(7): 464–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Goldberg, J. F. and Harrow, M. Subjective Life Satisfaction and Objective Functional Outcome in Bipolar and Unipolar Mood Disorders: a Longitudinal Analysis. J.Affect.Disord. 2005;89(1–3):79–89.PubMedCrossRefGoogle Scholar
  28. 28.
    Torrance, G. W. Measurement of Health State Utilities for Economic Appraisal. J.Health Econ. 1986; 5(1): 1–30.PubMedCrossRefGoogle Scholar
  29. 29.
    Torrance, G. W. Preferences for Health Outcomes and Cost-Utility Analysis. Am. J. Manag. Care. 1997;3 Suppl:S8–20.Google Scholar
  30. 30.
    Revicki, D. A., Hanlon, J., Martin, S., Gyulai, L., Nassir, Ghaemi S., Lynch, F., Mannix, S., and Kleinman, L. Patient-Based Utilities for Bipolar Disorder-Related Health States. J.Affect.Disord. 2005;87(2–3):203–10.PubMedCrossRefGoogle Scholar
  31. 31.
    Wells, K. B. and Sherbourne, C. D. Functioning and Utility for Current Health of Patients With Depression or Chronic Medical Conditions in Managed, Primary Care Practices. Arch.Gen.Psychiatry 1999; 56(10): 897–904.PubMedCrossRefGoogle Scholar
  32. 32.
    Tsevat, J., Keck, P. E., Hornung, R. W., and McElroy, S. L. Health Values of Patients With Bipolar Disorder. Qual.Life Res. 2000; 9(5): 579–86.PubMedCrossRefGoogle Scholar
  33. 33.
    Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., and Roine, R. Use of Quality-Adjusted Life Years for the Estimation of Effectiveness of Health Care: A Systematic Literature Review. Int.J.Technol.Assess.Health Care 2006; 22(2): 235–41.PubMedGoogle Scholar
  34. 34.
    Peveler, R., Kendrick, T., Buxton, M., Longworth, L., Baldwin, D., Moore, M., Chatwin, J., Goddard, J., Thornett, A., Smith, H., Campbell, M., and Thompson, C. A Randomised Controlled Trial to Compare the Cost-Effectiveness of Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors and Lofepramine. Health Technol.Assess. 2005; 9(16): 1–134, iii.PubMedGoogle Scholar
  35. 35.
    Vojta, C., Kinosian, B., Glick, H., Altshuler, L., and Bauer, M. S. Self-Reported Quality of Life Across Mood States in Bipolar Disorder. Compr.Psychiatry 2001; 42(3): 190–5.PubMedCrossRefGoogle Scholar
  36. 36.
    EuroQol–a New Facility for the Measurement of Health-Related Quality of Life. The EuroQol Group. Health Policy 1990; 16(3): 199–208.CrossRefGoogle Scholar
  37. 37.
    Zhang, H., Wisniewski, S. R., Bauer, M. S., Sachs, G. S., and Thase, M. E. Comparisons of Perceived Quality of Life Across Clinical States in Bipolar Disorder: Data From the First 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Participants. Compr.Psychiatry 2006; 47(3): 161–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Sachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., Wisniewski, S. R., Lavori, P., Lebowitz, B., Rudorfer, M., Frank, E.,Nierenberg, A. A., Fava, M., Bowden, C., Ketter, T., Marangell, L., Calabrese, J., Kupfer, D., and Rosenbaum, J. F. Rationale, Design, and Methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol.Psychiatry 2003; 53(11): 1028–42.PubMedCrossRefGoogle Scholar
  39. 39.
    MacQueen, G. M., Young, L. T., and Joffe, R. T. A Review of Psychosocial Outcome in Patients With Bipolar Disorder. Acta Psychiatr.Scand. 2001; 103(3): 163–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Dion, G. L., Tohen, M., Anthony, W. A., and Waternaux, C. S. Symptoms and Functioning of Patients With Bipolar Disorder Six Months After Hospitalization. Hosp.Community Psychiatry 1988; 39(6): 652–7.PubMedGoogle Scholar
  41. 41.
    Harrow, M., Goldberg, J. F., Grossman, L. S., and Meltzer, H. Y. Outcome in Manic Disorders. A Naturalistic Follow-Up Study. Arch.Gen.Psychiatry 1990; 47(7): 665–71.PubMedGoogle Scholar
  42. 42.
    Tohen, M., Waternaux, C. M., and Tsuang, M. T. Outcome in Mania. A 4-Year Prospective Follow-Up of 75 Patients Utilizing Survival Analysis. Arch.Gen.Psychiatry 1990; 47(12): 1106–11.PubMedGoogle Scholar
  43. 43.
    Goldberg, J. F., Harrow, M., and Grossman, L. S. Course and Outcome in Bipolar Affective Disorder: a Longitudinal Follow-Up Study. Am.J.Psychiatry 1995; 152(3): 379–84.PubMedGoogle Scholar
  44. 44.
    Fagiolini, A., Kupfer, D. J., Masalehdan, A., Scott, J. A., Houck, P. R., and Frank, E. Functional Impairment in the Remission Phase of Bipolar Disorder. Bipolar.Disord. 2005; 7(3): 281–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Bauer, M. S., Kirk, G. F., Gavin, C., and Williford, W. O. Determinants of Functional Outcome and Healthcare Costs in Bipolar Disorder: a High-Intensity Follow-Up Study. J.Affect.Disord. 2001; 65(3): 231–41.PubMedCrossRefGoogle Scholar
  46. 46.
    Cooke, R. G., Robb, J. C., Young, L. T., and Joffe, R. T. Well-Being and Functioning in Patients With Bipolar Disorder Assessed Using the MOS 20-ITEM Short Form (SF-20). J.Affect.Disord. 1996; 39(2): 93–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Robb, J. C., Cooke, R. G., Devins, G. M., Young, L. T., and Joffe, R. T. Quality of Life and Lifestyle Disruption in Euthymic Bipolar Disorder. J.Psychiatr.Res. 1997; 31(5): 509–17.PubMedCrossRefGoogle Scholar
  48. 48.
    Robb, J. C., Young, L. T., Cooke, R. G., and Joffe, R. T. Gender Differences in Patients With Bipolar Disorder Influence Outcome in the Medical Outcomes Survey (SF-20) Subscale Scores. J.Affect.Disord. 1998; 49(3): 189–93.PubMedCrossRefGoogle Scholar
  49. 49.
    Wells, K. B., Stewart, A., Hays, R. D., Burnam, M. A., Rogers, W., Daniels, M., Berry, S., Greenfield, S., and Ware, J. The Functioning and Well-Being of Depressed Patients. Results From the Medical Outcomes Study. JAMA 1989; 262(7): 914–9.Google Scholar
  50. 50.
    Flanagan, J. C. A Research Approach to Improving Our Quality of Life. American Psychology 1978;33:138–147.CrossRefGoogle Scholar
  51. 51.
    Devins, G. M., Edworthy, S. M., Seland, T. P., Klein, G. M., Paul, L. C., and Mandin, H. Differences in Illness Intrusiveness Across Rheumatoid Arthritis, End-Stage Renal Disease, and Multiple Sclerosis. J.Nerv.Ment.Dis. 1993; 181(6): 377–81.PubMedCrossRefGoogle Scholar
  52. 52.
    Hamilton, M. Development of a Rating Scale for Primary Depressive Illness. British Journal of the Society of Clinical Psychology 1967;6:278–96.Google Scholar
  53. 53.
    MacQueen, G. M., Young, L. T., Robb, J. C., Cooke, R. G., and Joffe, R. T. Levels of Functioning and Well-Being in Recovered Psychotic Versus Nonpsychotic Mania. J.Affect.Disord. 1997; 46(1): 69–72.PubMedCrossRefGoogle Scholar
  54. 54.
    MacQueen, G. M., Young, L. T., Robb, J. C., Marriott, M., Cooke, R. G., and Joffe, R. T. Effect of Number of Episodes on Wellbeing and Functioning of Patients With Bipolar Disorder. Acta Psychiatr.Scand. 2000; 101(5): 374–81.PubMedCrossRefGoogle Scholar
  55. 55.
    Ozer, S., Ulusahin, A., Batur, S., Kabakci, E., and Saka, M. C. Outcome Measures of Interepisode Bipolar Patients in a Turkish Sample. Social Psychiatry and Psychiatric Epidemiology 2002; 37(1): 31–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Rapaport, M. H.; Clary, C. M.; Judd, L. L. The Impact of Depression and Its Treatment. Presented at the 154th Annual Meeting of the American Psychiatric Association, New Orleans, La. 2001.Google Scholar
  57. 57.
    Michalak, E. E., Tam, E. M., Manjunath, C. V., Solomons, K., Levitt, A. J., Levitan, R., Enns, M., Morehouse, R., Yatham, L. N., and Lam, R. W. Generic and Health-Related Quality of Life in Patients With Seasonal and Nonseasonal Depression. Psychiatry Res. 2004; 128(3): 245–51.PubMedCrossRefGoogle Scholar
  58. 58.
    Miller, I. W., Keitner, G. I., Schatzberg, A. F., Klein, D. N., Thase, M. E., Rush, A. J., Markowitz, J. C., Schlager, D. S., Kornstein, S. G., Davis, S. M., Harrison, W. M., and Keller, M. B. The Treatment of Chronic Depression, Part 3: Psychosocial Functioning Before and After Treatment With Sertraline or Imipramine. J.Clin.Psychiatry 1998; 59(11): 608–19.PubMedGoogle Scholar
  59. 59.
    Young, R. C., Biggs, J. T., Ziegler, V. E., and Meyer, D. A. A Rating Scale for Mania: Reliability, Validity and Sensitivity. Br.J.Psychiatry 1978;133:429–35.PubMedCrossRefGoogle Scholar
  60. 60.
    Revicki, D. A., Paramore, L. C., Sommerville, K. W., Swann, A. C., and Zajecka, J. M. Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes. J.Clin.Psychiatry 2003; 64(3): 288–94.PubMedCrossRefGoogle Scholar
  61. 61.
    Calabrese, J. R., Keck, P. E., Jr., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., and Mullen, J. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression. Am.J.Psychiatry 2005; 162(7): 1351–60.PubMedCrossRefGoogle Scholar
  62. 62.
    Namjoshi, M. A., Rajamannar, G., Jacobs, T., Sanger, T. M., Risser, R., Tohen, M. F., Breier, A., and Keck, P. E. Economic, Clinical, and Quality-of-Life Outcomes Associated With Olanzapine Treatment in Mania. Results From a Randomized Controlled. J.Affect.Disord. 2002;69(1–3):109–18.Google Scholar
  63. 63.
    Shi, L., Namjoshi, M. A., Zhang, F., Gandhi, G., Edgell, E. T., Tohen, M., Breier, A., and Haro, J. M. Olanzapine Versus Haloperidol in the Treatment of Acute Mania: Clinical Outcomes, Health-Related Quality of Life and Work Status. Int.Clin.Psychopharmacol. 2002; 17(5): 227–37.PubMedCrossRefGoogle Scholar
  64. 64.
    Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M. C., Lawson, W. B., Emsley, R. A., Zhang, F., Baker, R. W., Risser, R. C., Namjoshi, M. A., Evans, A. R., and Breier, A. A 12-Week, Double-Blind Comparison of Olanzapine Vs Haloperidol in the Treatment of Acute Mania. Arch.Gen.Psychiatry 2003; 60(12): 1218–26.PubMedCrossRefGoogle Scholar
  65. 65.
    Namjoshi, M. A., Risser, R., Shi, L., Tohen, M., and Breier, A. Quality of Life Assessment in Patients With Bipolar Disorder Treated With Olanzapine Added to Lithium or Valproic Acid. J.Affect.Disord. 2004; 81(3): 223–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Lehman, A. F. A Quality of Life Interview for the Chronically Mentally Ill. Evaluation and Program Planning 1988;(11):51–62.CrossRefGoogle Scholar
  67. 67.
    Hunt, S. M. and McKenna, S. P. The QLDS: a Scale for the Measurement of Quality of Life in Depression. Health Policy 1992; 22(3): 307–19.PubMedCrossRefGoogle Scholar
  68. 68.
    Shi, L., Namjoshi, M. A., Swindle, R., Yu, X., Risser, R., Baker, R. W., and Tohen, M. Effects of Olanzapine Alone and Olanzapine/Fluoxetine Combination on Health-Related Quality of Life in Patients With Bipolar Depression: Secondary Analyses of a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Clin.Ther. 2004; 26(1): 125–34.PubMedCrossRefGoogle Scholar
  69. 69.
    Revicki, D. A., Paramore, L. C., Sommerville, K. W., Swann, A. C., and Zajecka, J. M. Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes. J.Clin.Psychiatry 2003; 64(3): 288–94.PubMedCrossRefGoogle Scholar
  70. 70.
    Kocsis, J. H., Zisook, S., Davidson, J., Shelton, R., Yonkers, K., Hellerstein, D. J., Rosenbaum, J., and Halbreich, U. Double-Blind Comparison of Sertraline, Imipramine, and Placebo in the Treatment of Dysthymia: Psychosocial Outcomes. Am.J.Psychiatry 1997; 154(3): 390–5.PubMedGoogle Scholar
  71. 71.
    Suppes, T., Dennehy, E. B., Swann, A. C., Bowden, C. L., Calabrese, J. R., Hirschfeld, R. M., Keck, P. E., Jr., Sachs, G. S., Crismon, M. L., Toprac, M. G., and Shon, S. P. Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. J.Clin.Psychiatry 2002; 63(4): 288–99.PubMedGoogle Scholar
  72. 72.
    Scott, J. and Colom, F. Psychosocial Treatments for Bipolar Disorders. Psychiatr.Clin.North Am. 2005; 28(2): 371–84.PubMedCrossRefGoogle Scholar
  73. 73.
    Otto, M. W., Reilly-Harrington, N., and Sachs, G. S. Psychoeducational and Cognitive-Behavioral Strategies in the Management of Bipolar Disorder. J.Affect.Disord. 2003;73(1–2):171–81.PubMedCrossRefGoogle Scholar
  74. 74.
    Miklowitz, D. J., Goldstein, M. J., Nuechterlein, K. H., Snyder, K. S., and Mintz, J. Family Factors and the Course of Bipolar Affective Disorder. Arch.Gen.Psychiatry 1988; 45(3): 225–31.PubMedGoogle Scholar
  75. 75.
    Miklowitz, D. J. and Goldstein, M. J., Bipolar Disorder: A Family-Focused Treatment Approach. New York: Guilford Press; 1997.Google Scholar
  76. 76.
    Frank, E., Swartz, H. A., and Kupfer, D. J. Interpersonal and Social Rhythm Therapy: Managing the Chaos of Bipolar Disorder [In Process Citation]. Biol.Psychiatry 2000; 48(6): 593–604.PubMedCrossRefGoogle Scholar
  77. 77.
    Patelis-Siotis, I., Young, L. T., Robb, J. C., Marriott, M., Bieling, P. J., Cox, L. C., and Joffe, R. T. Group Cognitive Behavioral Therapy for Bipolar Disorder: a Feasibility and Effectiveness Study. J.Affect.Disord. 2001; 65(2): 145–53.PubMedCrossRefGoogle Scholar
  78. 78.
    Dogan, S. and Sabanciogullari, S. The Effects of Patient Education in Lithium Therapy on Quality of Life and Compliance. Arch.Psychiatr.Nurs. 2003; 17(6): 270–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Michalak, E. E., Yatham, L. N., Wan, D. D., and Lam, R. W. Perceived Quality of Life in Patients With Bipolar Disorder. Does Group Psychoeducation Have an Impact? Can.J.Psychiatry 2005; 50(2): 95–100.PubMedGoogle Scholar
  80. 80.
    Michalak, E. E., Yatham, L. N., Kolesar, S., and Lam, R. W. Bipolar Disorder and Quality of Life: a Patient-Centered Perspective. Qual.Life Res. 2006; 15(1): 25–37.PubMedCrossRefGoogle Scholar
  81. 81.
    Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., and Young, A. H. Hypothalamic-Pituitary-Adrenal Axis Function in Patients with Bipolar Disorder. Br.J.Psychiatry 2004;184:496–502.PubMedCrossRefGoogle Scholar
  82. 82.
    Carlson, L. E., Speca, M., Patel, K. D., and Goodey, E. Mindfulness-Based Stress Reduction in Relation to Quality of Life, Mood, Symptoms of Stress and Levels of Cortisol, Dehydroepiandrosterone Sulfate (DHEAS) and Melatonin in Breast and Prostate Cancer Outpatients. Psychoneuroendocrinology 2004; 29(4): 448–74.PubMedCrossRefGoogle Scholar
  83. 83.
    Thompson, J. M., Gallagher, P., Hughes, J. H., Watson, S., Gray, J. M., Ferrier, I. N., and Young, A. H. Neurocognitive Impairment in Euthymic Patients With Bipolar Affective Disorder. Br.J.Psychiatry 2005;186:32–40.PubMedCrossRefGoogle Scholar
  84. 84.
    Patrick, D. L. and Deyo, R. A. Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life. Med.Care 1989;27(3 Suppl):S217–S232.PubMedCrossRefGoogle Scholar
  85. 85.
    Michalak, E. E., Yatham, L. N., Maxwell, V., Hale, S., and Lam, R. The Impact of Bipolar Disorder Upon Work Functioning: A Qualitative Analysis. In press, Bipolar Disord.Google Scholar

Copyright information

© springer 2007

Authors and Affiliations

  • Erin E. Michalak
    • 1
  • Greg Murray
    • 2
  • Allan H. Young
    • 1
  • Raymond W. Lam
    • 1
  1. 1.Department of PsychiatryUniversity of BritishColumbiaCanada
  2. 2.Faculty of Life and Social SciencesSwinburne University of TechnologyHawthornAustralia

Personalised recommendations